Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int J Lab Hematol ; 35(6): 658-65, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23738834

ABSTRACT

INTRODUCTION: Cord blood (CB) is an important source of hematopoietic stem cells and reflects the hematologic status of neonates. ABX Pentra DX 120 (Horiba Medical, Montpellier, France) and Sysmex XE-2100 (Sysmex, Kobe, Japan) were compared in 200 CB specimens. METHODS: Complete blood count parameters including white blood cell (WBC) differential counts were compared between the two analyzers. Double differential matrix (DDX) by ABX Pentra DX 120 and hematopoietic progenitor cell (HPC) by Sysmex XE-2100 were compared with CD34(+) cells by flow cytometry. RESULTS: Most of the parameters showed acceptable correlation between the two analyzers. Although WBC differential of both analyzers showed acceptable correlation with manual counts, mononuclear cells (MNC) by ABX Pentra DX 120 better correlated with manual count than MNC by Sysmex XE-2100. NRBC by Sysmex XE-2100 better correlated with manual count than NRBC by ABX Pentra DX 120. ABX Pentra DX 120 showed better flagging performances. DDX better correlated with CD34(+) cells than HPC. CONCLUSION: Although the results from both analyzers are mostly interchangeable and reliable in CB specimens, flagging performance of ABX Pentra DX 120 seems to be superior to that of Sysmex XE-2100. DDX by ABX Pentra DX 120 would be valuable to evaluate the quality of CB for further therapeutic utilization.


Subject(s)
Antigens, CD34/metabolism , Fetal Blood/cytology , Flow Cytometry/instrumentation , Flow Cytometry/standards , Adult , Blood Cell Count/instrumentation , Blood Cell Count/methods , Blood Cell Count/standards , Female , Flow Cytometry/methods , Hematopoietic Stem Cells/metabolism , Humans , Infant, Newborn , Middle Aged , Young Adult
2.
Br J Radiol ; 84(999): 204-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20959367

ABSTRACT

OBJECTIVES: This study aimed to evaluate the efficacy and safety of interventional management for various intractable complications following caesarean section. METHODS: Between August 2005 and September 2009, 18 consecutive women were referred to interventional radiology for treatment of complications developing after caesarean section. Complications included vaginal bleeding (n = 14), haemoperitoneum with abdominal wall haematoma (n = 2), caesarean scar pregnancy (CSP) (n = 1) and post-caesarean fluid collection (n = 1). RESULTS: 17 women underwent transcatheter arterial embolisation (TAE) with a variety of embolic materials, and two women underwent percutaneous drainage (PCD) for fluid collection and haemoperitoneum. 5 of the 14 women with vaginal bleeding had extravasation of contrast media on angiography; the other 9 had no visible bleeding foci. The two women with haemoperitoneum with abdominal wall haematoma had injury to the inferior epigastric artery from angiography. TAE and PCD were successfully performed in both women. The CSP was successfully managed and the serum ß-human chorionic gonadotropin (ß-hCG) level finally normalised. Hysterectomy or dilatation and curretage was required in women with placenta accrete and undetectable bleeding foci. CONCLUSION: Interventional management including TAE and PCD is effective and safe in controlling complications following caesarean section. Use of these procedures can help avoid high-risk surgery, but subsequent procedures including hysterectomy may be required in cases of placental abnormalities and undetectable bleeding foci.


Subject(s)
Cesarean Section/adverse effects , Cicatrix/diagnostic imaging , Hematoma/diagnostic imaging , Hemoperitoneum/diagnostic imaging , Postoperative Hemorrhage/diagnostic imaging , Radiology, Interventional/methods , Abdominal Wall , Adult , Cicatrix/surgery , Drainage/methods , Embolization, Therapeutic/methods , Exudates and Transudates/diagnostic imaging , Female , Hematoma/therapy , Hemoperitoneum/therapy , Humans , Hysterectomy/methods , Peritoneal Cavity/diagnostic imaging , Postoperative Hemorrhage/therapy , Pregnancy , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
3.
Anaesth Intensive Care ; 38(5): 924-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20865880

ABSTRACT

In several recent clinical trials on cardiac surgery patients, remote ischaemic preconditioning (RIPC) showed a powerful myocardial protective effect. However the effect of RIPC has not been studied in patients undergoing off-pump coronary artery bypass graft surgery. We evaluated whether RIPC could induce myocardial protection in off-pump coronary artery bypass graft surgery patients. Patients undergoing elective off-pump coronary artery bypass graft surgery were randomly allocated to the RIPC (n = 65) or control group (n = 65). After induction of anaesthesia, RIPC was induced by four cycles of five-minute ischaemia and reperfusion on the upper limb using a pneumatic cuff. Anaesthesia was maintained with sevoflurane, remifentanil and vecuronium. Myocardial injury was assessed by troponin I before surgery and 1, 6, 12, 24, 48 and 72 hours after surgery. There were no statistical differences in troponin I levels between RIPC and control groups (P = 0.172). Although RIPC reduced the total amount of troponin I (area under the curve of troponin increase) by 26%, it did not reach statistical significance (RIPC group 53.2 +/- 72.9 hours x ng/ml vs control group 67.4 +/- 97.7 hours x ng/ml, P = 0.281). In this study, RIPC by upper limb ischaemia reduced the postoperative myocardial enzyme elevation in off-pump coronary artery bypass graft surgery patients, but this did not reach statistical significance. Further study with a larger number of patients may be needed to fully evaluate the clinical effect of RIPC in off-pump coronary artery bypass graft surgery patients.


Subject(s)
Coronary Artery Bypass/methods , Ischemic Preconditioning, Myocardial/methods , Myocardial Reperfusion Injury/prevention & control , Troponin I/blood , Aged , Area Under Curve , Arm/blood supply , Female , Humans , Male , Middle Aged , Myocardial Reperfusion Injury/etiology , Pilot Projects , Time Factors
4.
Br J Anaesth ; 103(4): 490-5, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19687032

ABSTRACT

BACKGROUND: This prospective, randomized study was designed to compare remifentanil and magnesium sulphate during middle ear surgery in terms of postoperative pain and other complications. METHODS: Eighty patients undergoing middle ear surgery were enrolled in the study. Patients were randomized into two groups of 40 to receive remifentanil (Group R) or magnesium sulphate (Group M) infusion. Propofol 2 mg kg(-1) was administered to induce anaesthesia, which was maintained using sevoflurane. Group R received a continuous infusion of remifentanil titrated between 3 and 4 ng ml(-1) using target-controlled infusion, whereas Group M received an i.v. magnesium sulphate bolus of 50 mg kg(-1) followed by a 15 mg kg(-1) h(-1) continuous infusion to maintain a mean arterial pressure (MAP) between 60 and 70 mm Hg. Haemodynamic variables, surgical conditions, postoperative pain, and adverse effects, such as postoperative nausea and vomiting (PONV) and shivering, were recorded. RESULTS: Controlled hypotension was well maintained in both groups. MAP and heart rate were higher in Group R than in Group M after operation. Surgical conditions were not different between the two groups. Postoperative pain scores were significantly lower in Group M than in Group R (P<0.05). Seventeen patients in Group R (43%) and seven patients in Group M (18%) developed PONV (P=0.01). CONCLUSIONS: Both magnesium sulphate and remifentanil when combined with sevoflurane provided adequate controlled hypotension and proper surgical conditions for middle ear surgery. However, patients administered magnesium sulphate had a more favourable postoperative course with better analgesia and less shivering and PONV.


Subject(s)
Antihypertensive Agents/therapeutic use , Ear, Middle/surgery , Hypotension, Controlled/methods , Magnesium Sulfate/therapeutic use , Piperidines/therapeutic use , Adult , Analgesics/therapeutic use , Analgesics, Opioid/therapeutic use , Anesthesia, General/methods , Blood Pressure/drug effects , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Pain, Postoperative/prevention & control , Postoperative Nausea and Vomiting/prevention & control , Prospective Studies , Remifentanil
5.
J Colloid Interface Sci ; 269(2): 503-13, 2004 Jan 15.
Article in English | MEDLINE | ID: mdl-14654413

ABSTRACT

We present a light-scattering technique for the measurement of the microrheological properties of viscoelastic liquids in small volumes over a large frequency range (on the order of eight decades). The accuracy of the method for model viscoelastic liquids (polyethylene oxide solutions in water) is demonstrated by comparing the results with conventional mechanical measurements of the loss and storage moduli. Then we show that the method can be used to measure variations in viscoelastic properties in a heterogeneous system by measuring the variation in the moduli with position (and time) across a liquid/liquid interface between a viscoelastic polymer solution and a Newtonian liquid.

6.
J Korean Med Sci ; 8(5): 380-4, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8305146

ABSTRACT

Gonadoblastoma and dysgerminoma developed in a 24-year-old phenotypic female patient with 46,XY pure gonadal dysgenesis. This patient presented with primary amenorrhea. Clinical characteristics showed a typical stigmata of gonadal dysgenesis: primary amenorrhea, sexual infantilism, a small uterus and bilateral streak gonads. A 46,XY karyotype was made by lymphocyte culture. The patient was counseled to undergo a prophylactic bilateral gonadectomy, but she refused. Three years and three months after the initial diagnosis she felt a growing pelvic mass. Bilateral gonadectomy and total hysterectomy were performed. Histological examination revealed gonadoblastoma and dysgerminoma on both gonads. After surgery the patient received radiation therapy and also was started on hormone replacement therapy. Two years and two months after treatment by surgery the patient is well and free of recurrence.


Subject(s)
Dysgerminoma/etiology , Gonadal Dysgenesis, 46,XY/complications , Gonadoblastoma/etiology , Ovarian Neoplasms/etiology , Adult , Dysgerminoma/pathology , Dysgerminoma/therapy , Female , Gonadoblastoma/pathology , Gonadoblastoma/therapy , Humans , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...